Platelets and Neurodegenerative Diseases: Current Knowledge and Future Perspectives.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
    • Publication Information:
      Original Publication: Basel, Switzerland : MDPI, [2000-
    • Subject Terms:
    • Abstract:
      Platelets have a fundamental role in mediating hemostasis and thrombosis. However, more recently, a new idea is making headway, highlighting the importance of platelets as significant actors in modulating immune and inflammatory responses. In particular, platelets have an important role in the development of vascular amyloid-b-peptide(ab) deposits, known to play a relevant role in Alzheimer's disease (AD) through accumulation and deposition within the frontal cortex and hippocampus in the brain. The involvement of platelets in the pathogenesis of AD opens up the highly attractive possibility of applying antiplatelet therapy for the treatment and/or prevention of AD, but conclusive results are scarce. Even less is known about the potential role of platelets in mild cognitive impairment (MCI). The aim to this brief review is to summarize current knowledge on this topic and to introduce the new perspectives on the possible role of platelet activation as therapeutic target both in AD and MCI.
    • References:
      Haematologica. 2020 Apr;105(4):888-894. (PMID: 32139434)
      Lancet Neurol. 2008 Jan;7(1):41-9. (PMID: 18068522)
      Neurobiol Aging. 2007 Mar;28(3):336-42. (PMID: 16442186)
      Adv Clin Chem. 2012;56:155-73. (PMID: 22397031)
      Neurology. 2011 Jan 18;76(3):247-52. (PMID: 21242492)
      Sci Signal. 2016 May 24;9(429):ra52. (PMID: 27221710)
      PLoS One. 2014 Feb 28;9(2):e90523. (PMID: 24587388)
      Psychiatr Pol. 2016 Oct 31;50(5):1039-1052. (PMID: 27992895)
      Can J Neurol Sci. 2013 Sep;40(5):678-83. (PMID: 23968941)
      N Engl J Med. 2011 Jun 9;364(23):2227-34. (PMID: 21651394)
      Front Neurosci. 2019 Feb 28;13:164. (PMID: 30872998)
      Neurology. 2018 Jan 16;90(3):126-135. (PMID: 29282327)
      PLoS One. 2013;8(3):e59649. (PMID: 23544083)
      BMC Psychiatry. 2021 Oct 4;21(1):485. (PMID: 34607584)
      J Neurol. 2007 Apr;254(4):548-9. (PMID: 17380246)
      Curr Neuropharmacol. 2020;18(11):1106-1125. (PMID: 32484110)
      Eur Heart J. 2017 Mar 14;38(11):785-791. (PMID: 28039338)
      J Thromb Haemost. 2020 Nov;18(11):3029-3042. (PMID: 32790050)
      Circ Res. 2018 Jan 19;122(2):337-351. (PMID: 29348254)
      J Hematol Oncol. 2018 Oct 11;11(1):125. (PMID: 30305116)
      Sci Signal. 2016 May 24;9(429):fs9. (PMID: 27221708)
      Cancer Metastasis Rev. 2017 Jun;36(2):195-198. (PMID: 28667366)
      Curr Protein Pept Sci. 2018;19(6):612-622. (PMID: 28925903)
      Atherosclerosis. 2010 Dec;213(2):586-91. (PMID: 20940069)
      Cell Signal. 2016 Dec;28(12):1863-1871. (PMID: 27593518)
      Brain. 2019 Jun 1;142(6):1503-1527. (PMID: 31039256)
      J Psychiatr Res. 2011 Feb;45(2):220-4. (PMID: 20576277)
      Cytokine. 2019 Oct;122:154157. (PMID: 29198385)
      Exp Neurol. 1998 Dec;154(2):511-21. (PMID: 9878186)
      J Cereb Blood Flow Metab. 2010 Nov;30(11):1817-20. (PMID: 20717123)
      Thromb Res. 2009 Feb;123(4):587-91. (PMID: 18472144)
      Curr Alzheimer Res. 2010 Sep;7(6):517-26. (PMID: 20455862)
      Cell Rep. 2021 Jul 20;36(3):109419. (PMID: 34289368)
      Alzheimers Dement. 2017 Mar;13(3):285-295. (PMID: 28341066)
      Neurosci Bull. 2014 Feb;30(1):162-8. (PMID: 24353014)
      J Geriatr Psychiatry Neurol. 2011 Mar;24(1):9-18. (PMID: 20538969)
      Neurology. 2013 Jun 4;80(23):2112-20. (PMID: 23658380)
      Acta Neurol Scand. 2020 Mar;141(3):250-255. (PMID: 31715011)
      Platelets. 2004 Dec;15(8):475-8. (PMID: 15763888)
      J Am Med Dir Assoc. 2016 Oct 1;17(10):943-8. (PMID: 27502450)
      J Am Geriatr Soc. 2005 Apr;53(4):695-9. (PMID: 15817019)
      Cells. 2020 Feb 07;9(2):. (PMID: 32046119)
      Handb Exp Pharmacol. 2012;(210):3-22. (PMID: 22918725)
      J Alzheimers Dis. 2017;58(3):789-801. (PMID: 28482634)
      Neurology. 2012 Oct 9;79(15):1591-8. (PMID: 23019264)
      Mol Neurobiol. 2012 Apr;45(2):314-26. (PMID: 22274961)
      Med Clin North Am. 2019 Mar;103(2):263-293. (PMID: 30704681)
      ScientificWorldJournal. 2014 Mar 03;2014:781857. (PMID: 24729754)
      Cells. 2022 Mar 17;11(6):. (PMID: 35326465)
      J Alzheimers Dis. 2018;62(4):1841-1855. (PMID: 29614641)
      J Psychiatr Res. 2013 May;47(5):644-9. (PMID: 23395109)
      J Intern Med. 2004 Sep;256(3):240-6. (PMID: 15324367)
      J Thromb Haemost. 2010 Jan;8(1):148-56. (PMID: 19691485)
      Cell Signal. 2014 Sep;26(9):2040-50. (PMID: 24928203)
      JAMA. 2014 Dec 17;312(23):2551-61. (PMID: 25514304)
      Alzheimers Dement. 2023 Apr;19(4):1598-1695. (PMID: 36918389)
      Alzheimers Dement. 2011 May;7(3):263-9. (PMID: 21514250)
      Thromb Haemost. 2015 Aug 31;114(3):449-58. (PMID: 26293514)
      J Am Geriatr Soc. 2001 May;49(5):538-48. (PMID: 11380745)
      Alzheimers Dement. 2013 Jan;9(1):e-1-16. (PMID: 23360977)
      Int J Mol Sci. 2021 Sep 06;22(17):. (PMID: 34502546)
    • Contributed Indexing:
      Keywords: Alzheimer’s; amyloid; cognitive impairment; platelets
    • Accession Number:
      0 (Amyloid beta-Peptides)
      0 (Platelet Aggregation Inhibitors)
    • Publication Date:
      Date Created: 20240627 Date Completed: 20240627 Latest Revision: 20240629
    • Publication Date:
      20240629
    • Accession Number:
      PMC11203688
    • Accession Number:
      10.3390/ijms25126292
    • Accession Number:
      38927999